Giới Thiệu Công Ty
- Tên pháp lý: Chengdu Climb Pharmaceutical Technology Co., Ltd.
- Tên quốc tế: 成都克莱蒙医药科技有限公司 (Chengdu Climb Pharmaceutical Technology Co., Ltd.), Chengdu, Sichuan, China
- Tên thương hiệu: Climb
- Quốc gia đăng ký: China
- Địa chỉ: Room 909-911, Building C1, No. 88 Keyuan South Road, Tianfu Life Science & Technology Park, Gaoxin District, Chengdu 610041, Sichuan, China • Sichuan
- Năm thành lập: 2013
Mô tả:
Chengdu Climb Pharmaceutical Technology Co., Ltd., established in 2013, manufactures and trades active pharmaceutical ingredients and pharmaceutical intermediates and fine chemicals for markets worldwide. The company offers contract manufacturing services and is recognized for its international approvals, experienced R&D staff, production capacity and quality service.
Hoạt Động Kinh Doanh
Nguyên liệu Dược phẩm (API)
Nhà Cung CấpNhà Sản Xuất Nguyên Liệu Dược (API)Nhà Sản Xuất
Thành phẩm Dược
Nhà Sản Xuất
Dịch vụ Hợp đồng & Thuê ngoài
Nhà Cung Cấp Dịch Vụ
Thị Trường Tiêu Thụ
- East Asia: China, Democratic People's Republic of Korea, Republic of Korea, Japan
- Western Asia: Cyprus
- Northern Europe: Denmark, Finland, Iceland, Ireland, Norway, Sweden, United Kingdom
- Southern Europe: Andorra, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain, Vatican City
- Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland
Sản Phẩm/Dịch Vụ Chính
- Nguyên liệu Dược phẩm (API): Palbociclib, Etoricoxib, Active Pharmaceutical Ingredients, Brivaracetam, Avibactam Sodium, Apixaban, Vinpocetine, Parecoxib Sodium, Rupatadine fumarate, Macitentan, Moxifloxacin hydrochloride, Anacetrapib, Anamorelin, AZD9291, Cinacalcet HCl, Desvenlafaxine succinate, Macimorelin Acetate, Parecoxib Sodium cas:197502-82-2, Phenylethyl caffeate, ROLAPITANT, Tirofiban hydrochloride monohydrate
- Thành phẩm Dược: Lactulose oral solution, Finished antibiotic medicines
- Hóa chất Dược dụng: Active Pharmaceutical Ingredients, Pharmaceutical Intermediates, (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol, 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one, (S,S)-2,8-Diazabicyclo[4,3,0]nonane, Vincamine, 1-(6-Methylpyridin-3-yl)-2-[4(methylsulfonyl)phenyl]ethanone, 4-Methylsulfonyl phenyl acetic acid, 1-(6-methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone, 10,10-dimethylanthrone, 2-Chloro-1,3-bis(dimenthylamino)trimethinium hexafluorophosphate, 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3d] pyrimidine-6-carboxamide, 2'-(Chloromethyl)-4-fluoro-5-isopropyl-2-Methoxy-4'- (trifluoroMethyl)-1,1'-biphenyl, 2-(trifluoromethyl)pyridin -4-amine, 2,4-dichloro-6-(6-(trifluoromethyl)pyridin -2-yl)-1,3,5-triazine, (2S,5R)- 5-(benzyloxyamino)piperidine -2-carboxamide, (2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate, (2s,5r)-5-((phenylmethoxy)amino) -2-piperidinecarboxylic acid ethyl ester ethanedioate, (2S,5R)-benzyl 5-(benzyloxyamino)piperidine -2-carboxylate, 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone, 3-(Chloromethyl)-5-methylpyridine, (3R)-3-(Phenylmethyl)-3-piperidinecarboxylic acid trimethylhydrazide, 4-(4-Chlorobutyl)pyridine hydrochloride, 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7- oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridin, 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate, 4'-FLUORO-2'-METHOXY-5'-ISOPROPYL-4-TRIFLUOROMETHYL-1,1'-BIPHENYL-2-METHANOL, 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- 1H-pyrazolo[3,4-c]pyridine-3-carboxy, (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl] -4-methyl-1,3-oxazolidin- 2-one, 5-(4-Bromophenyl)-4,6-dichloropyrimidine, 5-Bromo-2-chloropyrimidine, 5-hydroxy-4-propyl-2(5H)-furanone, 5-Methyl-3,4-diphenyl- Isoxazole, 6-Benzofurancarboxylic acid, 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride, Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate, Methyl-6-methylnicotinate, methyl 6-(trifluoromethyl)picolinate, N-[2-Chloro-3-bis(dimethylamino)trimethinium, N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine, N-Butylsulfonyl-L-tyrosine, N-Propyl-sulfamide potassium salt, N-Propyl-sulfamide sodium salt, N-Propylsulfamide, N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze, (R)-1-(1-(bromomethoxy)ethyl) -3,5-bis(trifluoromethy l)benzene, (R)-Dihydro-4-propyl-2(3H)-furanone, Rucaparib, Tabersonine, VALDECOXIB
- Phân loại ATC (Giải phẫu - Điều trị - Hóa học): Desloratadine
Sản Phẩm & Dịch Vụ Của Chúng Tôi
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![(2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2s5r-5-benzyloxyaminopiperidine--2-carbo-78005.jpg&w=640&q=75)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
![Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fethyl-chloro4-methoxyphenylhydrazonoacet-78013.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fn1-2-dimethylaminoethyl--5-methoxy-n1-me-78016.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Chứng nhận
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bình luận
Lọc:
Sắp xếp theo:
Chưa có bình luận nào.
Để lại đánh giá & nhận xét